Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 3
2012 3
2013 6
2014 10
2015 7
2016 3
2017 6
2018 10
2019 4
2020 4
2021 7
2022 6
2023 5
2024 8
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M; ANSWER Study Investigators. Caraceni P, et al. Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1. Lancet. 2018. PMID: 29861076 Clinical Trial.
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept.
Vitale A, Cabibbo G, Iavarone M, Viganò L, Pinato DJ, Ponziani FR, Lai Q, Casadei-Gardini A, Celsa C, Galati G, Gambato M, Crocetti L, Renzulli M, Giannini EG, Farinati F, Trevisani F, Cillo U; HCC Special Interest Group of the Italian Association for the Study of the Liver. Vitale A, et al. Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9. Lancet Oncol. 2023. PMID: 37414020 Review.
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab.
Stella L, Cabibbo G, Celsa C, Ciccia R, Sparacino A, Piscaglia F, Tovoli F, Arleo A, Stefanini B, Iavarone M, D'Ambrosio R, Cerrito L, Pallozzi M, Santopaolo F, Marra F, Campani C, Mazzarelli C, Viganò R, Tortora R, Aghemo A, Nicola S, Pressiani T, Rimassa L, Bhoori S, Corallo S, Maiocchi L, Martini A, Soldà C, Russo FP, Gasbarrini A, Ponziani FR. Stella L, et al. Among authors: mazzarelli c. Liver Int. 2025 Oct;45(10):e70362. doi: 10.1111/liv.70362. Liver Int. 2025. PMID: 40980951 Free PMC article.
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation.
Montano-Loza AJ, Lytvyak E, Hirschfield G, Hansen BE, Ebadi M, Berney T, Toso C, Magini G, Villamil A, Nevens F, Van den Ende N, Pares A, Ruiz P, Terrabuio D, Trivedi PJ, Abbas N, Donato MF, Yu L, Landis C, Dumortier J, Dyson JK, van der Meer AJ, de Veer R, Pedersen M, Mayo M, Manns MP, Taubert R, Kirchner T, Belli LS, Mazzarelli C, Stirnimann G, Floreani A, Cazzagon N, Russo FP, Burra P, Zigmound U, Houri I, Carbone M, Mulinacci G, Fagiuoli S, Pratt DS, Bonder A, Schiano TD, Haydel B, Lohse A, Schramm C, Rüther D, Casu S, Verhelst X, Beretta-Piccoli BT, Robles M, Mason AL, Corpechot C; Global PBC Study Group. Montano-Loza AJ, et al. Among authors: mazzarelli c. J Hepatol. 2024 Oct;81(4):679-689. doi: 10.1016/j.jhep.2024.05.010. Epub 2024 May 29. J Hepatol. 2024. PMID: 38821360 Free article.
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.
Pompili E, Baldassarre M, Iannone G, Tedesco G, Nardelli S, Piano S, Alessandria C, Neri S, Foschi FG, Levantesi F, Caraceni P, Bernardi M, Zaccherini G; ANSWER Study Investigators. Pompili E, et al. Liver Int. 2024 Sep;44(9):2108-2113. doi: 10.1111/liv.16020. Epub 2024 Jun 27. Liver Int. 2024. PMID: 38934515 Clinical Trial.
Association Between Sustained Virological Response and Adverse Liver-related Events in Patients With Decompensated Hepatitis C Virus Cirrhosis.
van Velsen LM, Krassenburg LAP, Hirode G, Agarwal K, Foster GR, Cargill Z, Maan R, Manns MP, Wedemeyer H, Cornberg M, de Knegt RJ, Crespo G, Calleja JL, Ramji A, Brancaccio G, Morelli MC, Lenci I, Mazzarelli C, Vigano R, Angeli P, Burra P, Donato MF, Carrai P, Martini S, Caraceni P, Russo FP, Janssen HLA, Hansen BE, van der Meer AJ, Feld JJ, Sonneveld MJ. van Velsen LM, et al. Among authors: mazzarelli c. Clin Gastroenterol Hepatol. 2025 Sep 15:S1542-3565(25)00796-7. doi: 10.1016/j.cgh.2025.09.006. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40962195 Free article.
AISF position paper on HCV in immunocompromised patients.
Italian Association for the Study of the Liver (AISF). Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019 Jan;51(1):10-23. doi: 10.1016/j.dld.2018.09.022. Epub 2018 Oct 1. Dig Liver Dis. 2019. PMID: 30366813 Review.
71 results